SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
CLS Launches SoCal-Focused FAST
STARTUPS: Program Serves Earliest-Stage Biotech Companies
Biotech startups in Southern California will soon have the opportunity to speed up their path to commercialization.
$1B Acquisition for ResMed
SOFTWARE: German SaaS Provider Complements Offerings
ResMed (NYSE: RMD) announced on Tuesday (June 14) that it has entered an agreement to buy MEDIFOX DAN, a privately held German company specializing in out-of-hospital software solutions, for $1 billion.
CB Therapeutics Patents 'Magic' Mushroom Process
PHARMA: Company Makes Psychedelics Sustainable, Scalable
CB Therapeutics is bringing a bit of scientific “magic” of its own to the growing field of “magic” mushroom and other natural psychedelic compounds research.
Entos Pharma Moves into Torrey Pines Life Science Campus
BIOTECH: San Diego Now Canadian Firm’s US HQ
A Canadian pharmaceutical company – Entos Pharmaceuticals – has moved its U.S. operations to a Torrey Pines life science campus after starting them in a nearby incubator.
ResMed in $1B Deal to Acquire German SaaS Firm
ResMed (NYSE: RMD) announced on Tuesday (June 14) that it has entered an agreement to buy MEDIFOX DAN, a German company specializing in out-of-hospital software solutions, for $1 billion.
Scripps Offers Open-Source RNA Drug Development App
BIOTECH: Software Speeds up Process for Future Vaccines
Scripps Research is helping fellow scientists everywhere speed up the process of studying RNA for drug development. Last month, Scripps announced it had created an app named “Pytheas” for studying RNA molecules and that it would be offered to the scientific and academic communities for free as an open-source software tool.
Bristol Myers Squibb Buys Turning Point
BIOTECH: $4.1B Deal Expands ‘Oncology Franchise’
Bristol Myers Squibb (BMS) is further strengthening its ties to San Diego. On June 3, the New York-based global biopharmaceutical company announced it had acquired Turning Point Therapeutics, Inc., a clinical-stage precision oncology company based in San Diego.
Illumina CFO Samad Stepping Down
San Diego-based Illumina (NASDAQ: ILMN) has announced that its CFO, Sam Samad, will be leaving the company next month.
Pleno ‘Hypercoding’ Poised to Disrupt Clinical Testing
BIOTECH: Company Raises $15M Pre-Series A
Multi-omic instrument platform company Pleno, Inc. is poised to disrupt clinical testing.
Sharp Launches Funding Campaign at Groundbreaking
HEALTHCARE: Expansion at Serra Mesa Hospital Part of ‘ENVISION’
Sharp HealthCare is already bringing its “ENVISION” to life. On May 26, the Foundations of Sharp HealthCare broke ground on Sharp Memorial Hospital’s emergency and trauma center expansion – and used the occasion to announce a $250 million fundraising campaign to advance improvements at Sharp’s corporate headquarters, regional medical centers and specialty hospitals.
Illumina Supports Early STEM Education
BIOTECH: Firm’s DNA Sequencing Display Debuts at JA’s BizTown
Illumina, a San Diego stalwart since 1998, now has a high-profile presence at the McGrath Family JA BizTown in the Grantville community.
Bioscience Finance Officers to Convene in San Diego
EVENT: National Conference Held Amidst Industry’s Changing Economy
After two years of pandemic delays, the Association of Bioscience Financial Officers (ABFO) will finally hold its national conference in San Diego next week (June 5-8).
San Diego Tops in Office-to-Lab Conversions
San Diego is the second busiest region in the country when it comes to converting traditional office space to life science labs, according to a report by the commercial real estate brokerage CBRE.
Scripps to Lead Major Antiviral Push
PHARMA: $67M NIH Program Includes 16 U.S. Research Institutes
The National Institute of Allergy and Infectious Diseases (NIAID) announced earlier this month (May 18) it was sponsoring a major new antiviral drug development center to be led by La Jolla-based Scripps Research.
Travel Nurses Ease Critical Hospital Demand
HEALTHCARE: ‘Heroes in the Hotspots’
Demand for traveling nurses has slackened since the peak of the COVID-19 pandemic but staffing companies that represent the nurses said the demand remains high with far more openings than nurses to take them.
Prev Next